Tag: Pharma sector

Natco Pharma Q3 results: Net profit rises over 3-fold to Rs 212.7 crore | Company Results – Business Standard

Natco said its board of directors at their meeting held on February 14, 2024 have approved a third interim dividend

The company said its board has approved a proposal to buy back shares of up to Rs 600 crore

On Thursday, shares of Mankind Pharma jumped 5.72 per cent to close at Rs 2,250 apiece on the NSE |

Indian pharmaceutical firm Dr Reddy’s Laboratories beat estimates for third-quarter profit on Tuesday, helped by strong performance in its

Mumbai-headquartered Cipla saw a 32 per cent surge in year-on-year (Y-o-Y) net profit at Rs 1,055.9 crore for the

The settlement is the latest in a years-long effort to hold McKinsey accountable for its role in the opioid epidemic.

Lupin Atlantis Holdings, a wholly-owned subsidiary of Lupin, has signed an Asset Purchase Agreement with French pharmaceutical company Sanofi.

Zydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical Co Ltd, has entered into a

Dr Reddy’s Laboratories (DRL) said on Wednesday that it has entered into an exclusive collaboration with US-based Coya Therapeutics

Global pharma major Lupin on Thursday announced the launch of Vilfuro-G, the world’s first fixed-dose triple combination drug (FDC) for